US green lights novel HIV treatment
US regulators have approved a new option for treating HIV, marking the first therapy with a new mode of action in a decade.
Read More
Tag: Theratechnologies
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
